ReviewTouchREVIEWS in endocrinology2021

Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination.

Johan H Jendle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.